Recent Updates
Recently added Catalysts
AORT Positive Sentiment Score: 60/100

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2022 Financial Results Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full...

Key Takeaway: Artivion, Inc. (NYSE: AORT) announced it will release its fourth quarter and full year 2022 financial results on February 16, 2023, after market close. The company will host a teleconference and live webcast at 4:30 p.m. ET for discussions about the results, followed by a Q&A session with its CEO, Pat Mackin. The earnings press release will be available on its website in the Investors section, providing additional details and financial data.

Market Sentiment Analysis

POSITIVE FACTORS

  • Artivion is set to release its fourth quarter and full year 2022 financial results, indicating transparency.
  • The company is engaging investors with a teleconference and live webcast for detailed discussions on results.
  • Artivion's focus on aortic disease highlights its commitment to addressing significant healthcare needs.

Full Press Release Details

ATLANTA , Feb. 2, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT ), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full year 2022 financial results will be released on Thursday, February 16, 2023 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin , Chairman, President and Chief Executive Officer of Artivion.
To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET . The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13735085.
The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.
About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia , Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com .
Contacts:
Artivion D. Ashley Lee Executive Vice President & Chief Financial Officer Gilmartin Group LLC Brian Johnston / Lynn Lewis Phone: 332-895-3222 [email protected]
Phone: 770-419-3355
SOURCE Artivion, Inc.

21 %

Frequently Asked Questions

When will Artivion release its 2022 financial results?

Artivion will release its 2022 financial results on February 16, 2023.

How can I listen to the live teleconference?

Dial 201-689-8261 a few minutes before 4:30 p.m. ET to join the teleconference.

Where can I find the webcast and earnings press release?

Access the webcast and earnings press release on Artivion's website in the Investors section.

Who will host the Q&A session after the results announcement?

Pat Mackin, Chairman and CEO, will host the Q&A session following the results.

What major products does Artivion develop?

Artivion's major products include aortic stent grafts and On-X mechanical heart valves.

Last updated: Feb 2, 2023